Full Prescribing Info
Description
After reconstitution, 1 dose (0.5 ml) contains 50 micrograms of gE antigen1 adjuvanted with AS01B2.
1 Varicella Zoster Virus (VZV) glycoprotein E (gE) produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cells.
2 The GlaxoSmithKline proprietary AS01B Adjuvant System is composed of the plant extract Quillaja saponaria Molina, fraction 21 (QS-21) (50 micrograms) and 3-O-desacyl-4'-monophosphoryl lipid A (MPL) from Salmonella minnesota (50 micrograms).
Excipients/Inactive Ingredients: Powder (gE antigen): Sucrose, Polysorbate 80, Sodium dihydrogen phosphate dihydrate, Dipotassium phosphate.
Suspension (AS01B Adjuvant System): Dioleoyl phosphatidylcholine, Cholesterol, Sodium chloride, Disodium phosphate anhydrous, Potassium dihydrogen phosphate, Water for injections.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in